THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Backed by study, Pfizer intensifies Lipitor pitch

By Diedtra Henderson
Globe Staff / September 5, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

Pfizer Inc. , the world's largest drug company, is using the results of a study it sponsored to persuade doctors to switch patients to pricier doses of its blockbuster drug, Lipitor . And according to the latest sales figures, the marketing pitch is working. (Full article: 943 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly